[ET Net News Agency, 4 November 2024] IMMUNEONCO-B (01541) rose 9.5% to HK$7.92.
It hits an intra-day high of HK$7.98, and an intra-day low of HK$6.99. The total shares
traded was 7.57 million, with a value of HK$56.55m. The active buy/sell ratio is 59:41,
with net buying turnover of HK$9.87m. FUTU SEC INT'L accounts for greatest net responsive
buying turnover of HK$988,992, with volume weighted average price of HK$7.48. CHINA
INNOVATION MARKET SER accounts for greatest net responsive selling turnover of HK$2.81m,
with volume weighted average price of HK$7.469.

Basic Information
=================

---------------------------------
Nominal 7.920 % Chg +9.54%
High 7.980 Low 6.990
Shares Tr 7.57m Turnover 56.55m
10-D SMA 7.164 %H.V 132.886
20-D SMA 6.563 VWAP 7.474
50-D SMA 6.488 RSI14 58.834
---------------------------------
Status: Active buy/sell ratio is 59:41, with net buying turnover of HK$9.87m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
IMMUNEONCO-B (01541) 7.92 +9.54
INNOVENT BIO (01801) 39.65 +13.12
EVEREST MED-B (01952) 33.35 +7.58
LAEKNA-B (02105) 11.84 +29.68
WUXI XDC (02268) 22.80 +0.88
WUXI BIO (02269) 16.76 +2.70
JOINN (06127) 9.84 +12.71
BEIGENE (06160) 124.10 +0.40
AKESO (09926) 69.35 +1.69
REMEGEN (09995) 19.48 +0.93
---------------------------------------------
(ed)